Nancy A. Dreyer: There is a lot of discussion around diversity and inclusion in clinical trials, secondary data sources, etc. How much of a concern is this, from a drug approval and post-approval RWE standpoint?

In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Nancy A. Dreyer, Adjunct Professor of Epidemiology at the University of North Carolina, and Chief Scientific Officer, IQVIA Real-World Solutions, Retired.  View more Patti's People episodes here. Nancy A. Dreyer Adjunct Professor of Epidemiology at the University of North Carolina, and Chief Scientific Officer, IQVIA Real-World Solutions, Retired Nancy Dreyer is Adjunct Professor of Epidemiology at the University of North Carolina at Chapel Hill, a Trustee of Brandeis University and Chief Scientific Officer, IQVIA Real World Solutions. Recently retired from full-time employment, she maintains an active...